Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Volunteer Safety Study”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05625334
What this trial is testing

Study to Compare the Pharmacodynamics and Pharmacokinetics of Acetylsalicylic Acid Powder for Oral Inhalation With Non-enteric-coated Chewable Aspirin in Healthy Adults.

Who this might be right for
Healthy Volunteers
Vectura, Inc. 86
Early research (Phase 1)Study completedNCT00851734
What this trial is testing

A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed by an Open-Label Evaluation of LX214 in Patients With Keratoconjunctivitis Sicca (KCS)

Who this might be right for
Keratoconjunctivitis Sicca
Lux Biosciences, Inc. 35
Early research (Phase 1)Study completedNCT01725009
What this trial is testing

Multiple-dose Study of Levetiracetam Injection in Japanese and Caucasian Healthy Males

Who this might be right for
Healthy Volunteers
UCB Japan Co. Ltd. 32
Early research (Phase 1)Study completedNCT03294707
What this trial is testing

Single and Multiple Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of AG10

Who this might be right for
Amyloid Cardiomyopathy, Transthyretin-Related
Eidos Therapeutics, a BridgeBio company 56
Very early researchStudy completedNCT04559971
What this trial is testing

Evaluate the Safety, Tolerability, PK and PD of SLN124 in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Silence Therapeutics plc 24
Early research (Phase 1)Study completedNCT01835899
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Multiple Rising Oral Doses of BI 1015550 Powder for Oral Solution

Who this might be right for
Healthy
Boehringer Ingelheim 24
Early research (Phase 1)Study completedNCT06889064
What this trial is testing

Evaluate the Pharmacokinetic, Pharmacodynamic Characteristics and the Safety After Administration by Doses of BR1400-1, BR1400-2, BR1400-3 in Healthy Adult Volunteers

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 28
Early research (Phase 1)Study completedNCT05033444
What this trial is testing

A First in Human Study of the Safety, Tolerability and Pharmacokinetics of PRV-002 in Healthy Volunteers

Who this might be right for
Traumatic Brain Injury (TBI)
Odyssey Group International, Inc. 40
Early research (Phase 1)Study completedNCT05224609
What this trial is testing

Learn About the Study Medicine (Called Lorlatinib) in People With Liver Dysfunction

Who this might be right for
Moderate Hepatic ImpairmentSevere Hepatic ImpairmentHealthy Volunteers
Pfizer 21
Early research (Phase 1)Ended earlyNCT04475198
What this trial is testing

Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ST-2427

Who this might be right for
Acute, Post-operative Pain
SiteOne Therapeutics, Inc. 24
Early research (Phase 1)Study completedNCT00825084
What this trial is testing

Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects

Who this might be right for
Alzheimer's DiseaseHuntington's Disease
Pfizer 45
Early research (Phase 1)Study completedNCT04049409
What this trial is testing

Pharmacokinetic, Safety and Immunogenicity Study of CMAB809 and Herceptin in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Taizhou Mabtech Pharmaceutical Co.,Ltd 72
Early research (Phase 1)Study completedNCT01888393
What this trial is testing

Study of Lumacaftor in Combination With Ivacaftor in Subjects With Moderate Hepatic Impairment and Healthy Subjects

Who this might be right for
Hepatic ImpairmentHealthy
Vertex Pharmaceuticals Incorporated 23
Early research (Phase 1)Ended earlyNCT01164904
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Amgen 72
Testing effectiveness (Phase 2)Study completedNCT06101784
What this trial is testing

Single and Multiple Ascending Oral Doses of Avenanthramide

Who this might be right for
Inflammation
Montreal Heart Institute 92
Testing effectiveness (Phase 2)Active Not RecruitingNCT05856084
What this trial is testing

Immunogenicity and Safety of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 30 Years and Above

Who this might be right for
Herpes Zoster
MAXVAX Biotechnology Limited Liability Company 924
Early research (Phase 1)Study completedNCT03931447
What this trial is testing

A Safety and Tolerability Study of JNJ-72537634 in Healthy Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 31
Early research (Phase 1)Study completedNCT00739232
What this trial is testing

Single Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HSD-016

Who this might be right for
Healthy Subjects
Wyeth is now a wholly owned subsidiary of Pfizer 74
Early research (Phase 1)Study completedNCT07202663
What this trial is testing

Study of BB-025, Alone and After BB-031, in Healthy Volunteers

Who this might be right for
PharmacodynamicsPharmacokineticsHealthy Volunteers
Basking Biosciences, Inc. 72
Early research (Phase 1)Study completedNCT01298063
What this trial is testing

Influence of Mild and Moderate Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of Various Doses of Afatinib

Who this might be right for
Liver DiseasesHealthy
Boehringer Ingelheim 35
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation